Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks
Gilead Sciences’ stock is up 12% this year, topping a 1% gain for the NYSE Arca Pharmaceutical Index. - Mike Blake/REUTERS Chief Executives don’t usually brag about paying high tax rates. But with pharma tariffs looming, being a tax sucker is suddenly …